Clinical TrialsSearch results
Number of results: 356
Recruiting
- A Japanese Phase 2 study of 177Lu-PSMA-617 in participants with PSMA(+) mCRPC
- Prostate Cancer
- Yamauchi Kyosuke
- 2021-12-26
Recruiting
- Rehabilitation using tDCS for patients with consciousness disorders
- prolonged consciousness disorder
- Takahashi Chiaki
- 2024-09-24
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Recruiting
- Exploratory study of 24-hour intraocular pressure fluctuation profile in patients with primary open-angle glaucoma and healthy subjects with contact lens sensor
- Primary Open Angle Glaucoma (POAG)
- Higashide Tomomi
- 2023-08-04
Other
- Prospective study of high dose MTX with R-CHOP therapy for primary central nervous system lymphoma.
- Primary CNS lymphoma (CD20+ diffuse large B-cell lymphoma)
- Hematology and Immunology, Kanazawa Medical University
- 2008-09-01
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Phase III Randomized Study of Imatinib therapy in chornic phase chronic myeloid leukemia comparing standard dose-escalation with progressive dose-escalation (JALSG CML207study)
- Previously untreated Chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2007-09-15
Other
- Randomized phase III trial of erlotinib versus docetaxel for patients with previously treated advanced non-small cell lung cancer
- Previously treated non-small cell lung cancer
- National Hospital Organization Headquarters Center for Support and Education of Clinical Research
- 2009-08-11
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30